PL354083A1 - Zastosowanie baklofenu do leczenia alkoholizmuZastosowanie baklofenu do leczenia alkoholizmu - Google Patents

Zastosowanie baklofenu do leczenia alkoholizmuZastosowanie baklofenu do leczenia alkoholizmu

Info

Publication number
PL354083A1
PL354083A1 PL00354083A PL35408300A PL354083A1 PL 354083 A1 PL354083 A1 PL 354083A1 PL 00354083 A PL00354083 A PL 00354083A PL 35408300 A PL35408300 A PL 35408300A PL 354083 A1 PL354083 A1 PL 354083A1
Authority
PL
Poland
Prior art keywords
baclofen
treatment
alcoholism
alcoholics
abstinence
Prior art date
Application number
PL00354083A
Other languages
English (en)
Other versions
PL200525B1 (pl
Inventor
Gian LuigiGessa Gian Luigi Gessa
GiancarloColombo Giancarlo Colombo
GiovanniAddolorato Giovanni Addolorato
Original Assignee
Neuroscienze S.C.A R.L.Neuroscienze S.C.A R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroscienze S.C.A R.L.Neuroscienze S.C.A R.L. filed Critical Neuroscienze S.C.A R.L.Neuroscienze S.C.A R.L.
Publication of PL354083A1 publication Critical patent/PL354083A1/pl
Publication of PL200525B1 publication Critical patent/PL200525B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL354083A 1999-10-08 2000-10-05 Zastosowanie baklofenu do wytwarzania leku PL200525B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.
PCT/EP2000/009750 WO2001026638A2 (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism

Publications (2)

Publication Number Publication Date
PL354083A1 true PL354083A1 (pl) 2003-12-29
PL200525B1 PL200525B1 (pl) 2009-01-30

Family

ID=11383744

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354083A PL200525B1 (pl) 1999-10-08 2000-10-05 Zastosowanie baklofenu do wytwarzania leku

Country Status (11)

Country Link
EP (1) EP1217999B1 (pl)
AT (1) ATE300295T1 (pl)
AU (1) AU7914600A (pl)
CA (1) CA2386817C (pl)
DE (1) DE60021590T2 (pl)
DK (1) DK1217999T3 (pl)
ES (1) ES2246900T3 (pl)
HK (1) HK1048062A1 (pl)
IT (1) IT1319275B1 (pl)
PL (1) PL200525B1 (pl)
WO (1) WO2001026638A2 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
BRPI0413756A (pt) 2003-08-20 2006-10-31 Xenoport Inc composto, métodos para tratar ou evitar espasticidade ou um sintoma de espasticidade, doença de refluxo gastro-esofágico, vìcio em droga, vìcio em ou abuso de álcool, ou vìcio em ou abuso de nicotina, e tosse ou êmese em um paciente, e, composição farmacêutica
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US7585996B2 (en) 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
ES2601852T3 (es) 2008-01-25 2017-02-16 Xenoport, Inc. Forma cristalina de sales de calcio de ácidos (3S)-aminometil-5-metil-hexanoicos y métodos de uso
US7868043B2 (en) 2008-01-25 2011-01-11 Xenoport, Inc. Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
EP2250148B1 (en) 2008-01-25 2016-08-17 XenoPort, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
US7989641B2 (en) 2008-08-07 2011-08-02 Xenoport, Inc. Methods of synthesizing N-hydroxysuccinimidyl carbonates
US8299291B2 (en) 2008-08-07 2012-10-30 Xenoport, Inc. Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
KR20110117216A (ko) 2009-03-03 2011-10-26 제노포트 인코포레이티드 R-바클로펜 전구약물의 서방형 경구 투약 형태
EP2419401A2 (en) 2009-04-17 2012-02-22 XenoPort, Inc. GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAb RECEPTOR LIGANDS
DE102010011069A1 (de) 2010-03-11 2011-09-15 Susanne Haamann Verfahren zur gezielten pharmakologischen und co-psychotherapeutischen Behandlung der Alkoholabhängigkeit mit Baclofen und Nalmefen
US8580850B2 (en) 2011-08-11 2013-11-12 Xenoport, Inc. Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use
EP3244884A4 (en) * 2015-01-15 2018-07-25 Allaysis, LLC Intravenous baclofen formulations and treatment methods

Also Published As

Publication number Publication date
DK1217999T3 (da) 2005-11-28
WO2001026638A3 (en) 2002-02-28
AU7914600A (en) 2001-04-23
IT1319275B1 (it) 2003-09-26
CA2386817A1 (en) 2001-04-19
ITMI992107A0 (it) 1999-10-08
EP1217999B1 (en) 2005-07-27
EP1217999A2 (en) 2002-07-03
ATE300295T1 (de) 2005-08-15
PL200525B1 (pl) 2009-01-30
ITMI992107A1 (it) 2001-04-08
CA2386817C (en) 2009-05-12
HK1048062A1 (zh) 2003-03-21
WO2001026638A2 (en) 2001-04-19
DE60021590T2 (de) 2006-05-24
DE60021590D1 (de) 2005-09-01
ES2246900T3 (es) 2006-03-01

Similar Documents

Publication Publication Date Title
PL354083A1 (pl) Zastosowanie baklofenu do leczenia alkoholizmuZastosowanie baklofenu do leczenia alkoholizmu
AU144991S (en) Bottle
AU2002236527A1 (en) Nutrient supplements and methods for treating autism and for preventing the onset of autism
AU2001296601A1 (en) Systems and methods for supporting the delivery of streamed content
MY113079A (en) Estrogen agonists as remedies for cardiovascular diseases
AU2002232422A1 (en) Pump and diaphragm for use therein
EP2270046A3 (en) Methods and compositions for the treatment of hemolysis-associated diseases
AU6669401A (en) Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
AU2001245288A1 (en) Overhanging form system and method of using the same
EP0959897A4 (en) METHOD FOR REGULATING NITROGEN MONOXIDE PRODUCTION
UA32542C2 (uk) Спосіб безперервного зволоження сипких харчових продуктів і кормів та пристрій для його здійснення
GB9810327D0 (en) Fuel system and pump suitable for use therein
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
MX9801496A (es) Uso de compuestos de aminoadamantano como inmunorreguladores.
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
WO1996032109A3 (en) Levobupivacaine and its use as an anaesthetic in pregnant women
ES2113328A1 (es) Articulo de recubrimiento para camas y analogos, y procedimiento para su confeccion.
GB9626472D0 (en) New use of comt inhibitors
AU2001286000A1 (en) Composition, method for making same, implementing device and use of liquid mycelium
GB2256657B (en) Wall,clip for use in the wall and method of installing the wall
MXPA03002887A (es) Metodo y composicion para el tratamiento de sistemas de recoleccion de aguas negras.
MY121297A (en) A system for conversing a liquid substance in a flexible receptacle
WO1998017231A3 (en) Treatment and delivery of hydroxychloroquine
NL1000018C2 (en) Use of enzymes, such as beta-glucanase, in animal feeds
UA35705A (uk) Горілка особлива "кумир"